1. Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.
- Author
-
Licón-Muñoz Y, Avalos V, Subramanian S, Granger B, Martinez F, García-Montaño LA, Varela S, Moore D, Perkins E, Kogan M, Berto S, Chohan MO, Bowers CA, and Piccirillo SGM
- Subjects
- Humans, Cell Nucleus metabolism, Zinc Finger E-box-Binding Homeobox 1 metabolism, Zinc Finger E-box-Binding Homeobox 1 genetics, Wnt-5a Protein metabolism, Wnt-5a Protein genetics, Interleukin-1beta metabolism, Lateral Ventricles pathology, Lateral Ventricles metabolism, Gene Expression Regulation, Neoplastic, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, Microglia metabolism, Microglia pathology, Male, Glioblastoma pathology, Glioblastoma genetics, Glioblastoma metabolism, Tumor Microenvironment, Brain Neoplasms pathology, Brain Neoplasms genetics, Brain Neoplasms metabolism
- Abstract
The sub-ventricular zone (SVZ) is the most well-characterized neurogenic area in the mammalian brain. We previously showed that in 65% of patients with glioblastoma (GBM), the SVZ is a reservoir of cancer stem-like cells that contribute to treatment resistance and the emergence of recurrence. Here, we build a single-nucleus RNA-sequencing-based microenvironment landscape of the tumor mass and the SVZ of 15 patients and two histologically normal SVZ samples as controls. We identify a ZEB1-centered mesenchymal signature in the tumor cells of the SVZ. Moreover, the SVZ microenvironment is characterized by tumor-supportive microglia, which spatially coexist and establish crosstalks with tumor cells. Last, differential gene expression analyses, predictions of ligand-receptor and incoming/outgoing interactions, and functional assays reveal that the interleukin (IL)-1β/IL-1RAcP and Wnt-5a/Frizzled-3 pathways represent potential therapeutic targets in the SVZ. Our data provide insights into the biology of the SVZ in patients with GBM and identify potential targets of this microenvironment., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF